Display options
Cite
Hardy-Werbin M, Rocha P, Arpi O, et al. Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. Oncoimmunology. 2019;8(6):e1593810doi: 10.1080/2162402X.2019.1593810.
Hardy-Werbin, M., Rocha, P., Arpi, O., Taus, �. �., Nonell, L., Durán, X., Villanueva, X., Joseph-Pietras, D., Nolan, L., Danson, S., Griffiths, R., Lopez-Botet, M., Rovira, A., Albanell, J., Ottensmeier, C., & Arriola, E. (2019). Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. Oncoimmunology, 8(6), e1593810. https://doi.org/10.1080/2162402X.2019.1593810
Hardy-Werbin, Max, et al. "Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer." Oncoimmunology vol. 8,6 (2019): e1593810. doi: https://doi.org/10.1080/2162402X.2019.1593810
Hardy-Werbin M, Rocha P, Arpi O, Taus Á, Nonell L, Durán X, Villanueva X, Joseph-Pietras D, Nolan L, Danson S, Griffiths R, Lopez-Botet M, Rovira A, Albanell J, Ottensmeier C, Arriola E. Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. Oncoimmunology. 2019 Mar 27;8(6):e1593810. doi: 10.1080/2162402X.2019.1593810. eCollection 2019. PMID: 31069160; PMCID: PMC6492977.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2019 Mar 27;8(6):e1593810. doi: 10.1080/2162402X.2019.1593810. eCollection 2019.

Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer.

Oncoimmunology

Max Hardy-Werbin, Pedro Rocha, Oriol Arpi, Álvaro Taus, Lara Nonell, Xavier Durán, Xavier Villanueva, Deborah Joseph-Pietras, Luke Nolan, Sarah Danson, Richard Griffiths, Miguel Lopez-Botet, Ana Rovira, Joan Albanell, Christian Ottensmeier, Edurne Arriola

Affiliations

  1. Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  2. Universitat de Barcelona, Barcelona, Spain.
  3. Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain.
  4. Microarrays analysis service, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  5. Statistics department, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  6. NIHR Experimental Cancer Medicine Centre, Southampton, UK.
  7. Medical Oncology Department, University Hospital Southampton, Southampton, UK.
  8. Sheffield Experimental Cancer Medicine Centre, Weston Park Hospital, Sheffield, UK.
  9. The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK.
  10. Immunology unit, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  11. Universitat Pompeu Fabra, Barcelona, Spain.
  12. Cancer Science Unit, Faculty of Medicine, University of Southampton, Southampton, UK.

PMID: 31069160 PMCID: PMC6492977 DOI: 10.1080/2162402X.2019.1593810

[No abstract available.]

Keywords: biomarkers; cytokines; immunotherapy; ipilimumab; small cell lung cancer

References

  1. Am J Pathol. 2002 Jul;161(1):125-34 - PubMed
  2. Scand J Immunol. 2003 Feb;57(2):173-8 - PubMed
  3. Cancer Res. 1992 Apr 1;52(7):1695-8 - PubMed
  4. N Engl J Med. 2003 Oct 16;349(16):1543-54 - PubMed
  5. PLoS One. 2009 Nov 13;4(11):e7835 - PubMed
  6. Cell Mol Immunol. 2009 Dec;6(6):415-22 - PubMed
  7. Cancer. 2010 Apr 1;116(7):1767-75 - PubMed
  8. Anticancer Res. 2010 May;30(5):1773-8 - PubMed
  9. J Natl Cancer Inst. 2011 Jul 20;103(14):1112-22 - PubMed
  10. Br J Cancer. 2012 Mar 13;106(6):1153-9 - PubMed
  11. Ann Oncol. 2013 Jan;24(1):75-83 - PubMed
  12. Int J Cancer. 2013 May 1;132(9):1977-85 - PubMed
  13. PLoS One. 2012;7(12):e51862 - PubMed
  14. Cancer Res. 2013 Apr 15;73(8):2480-92 - PubMed
  15. Breast Cancer Res Treat. 2013 Jun;139(2):477-88 - PubMed
  16. Lancet Oncol. 2013 May;14(6):e218-28 - PubMed
  17. J Immunol. 2013 Nov 15;191(10):4903-7 - PubMed
  18. Cancers (Basel). 2011 Oct 13;3(4):3856-93 - PubMed
  19. Cancer Immunol Res. 2014 Feb;2(2):142-53 - PubMed
  20. J Transl Med. 2014 Jul 09;12:191 - PubMed
  21. Oncotarget. 2014 Jul 30;5(14):5246-56 - PubMed
  22. Oncoimmunology. 2014 Mar 17;3:e28245 - PubMed
  23. Thorac Surg Clin. 2014 Aug;24(3):257-66 - PubMed
  24. Science. 2015 Apr 3;348(6230):124-8 - PubMed
  25. Hepatology. 2015 Aug;62(2):505-20 - PubMed
  26. Nat Cell Biol. 2015 Jun;17(6):804-15 - PubMed
  27. Cancer Res. 2015 Aug 1;75(15):3098-107 - PubMed
  28. Lung Cancer. 2015 Nov;90(2):302-6 - PubMed
  29. Oncoimmunology. 2015 Nov 25;5(4):e1100788 - PubMed
  30. Lancet Oncol. 2016 Jul;17(7):883-895 - PubMed
  31. J Thorac Oncol. 2016 Sep;11(9):1511-21 - PubMed
  32. J Clin Oncol. 2016 Nov 1;34(31):3740-3748 - PubMed
  33. Oncoimmunology. 2016 Nov 1;5(12):e1249559 - PubMed
  34. Ann Oncol. 2017 Aug 1;28(8):1988-1995 - PubMed
  35. J Clin Oncol. 2017 Dec 1;35(34):3823-3829 - PubMed
  36. J Biomed Sci. 2017 Dec 04;24(1):90 - PubMed
  37. Oncoimmunology. 2017 Nov 27;7(2):e1395125 - PubMed
  38. Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):1034-1043 - PubMed
  39. N Engl J Med. 2018 Dec 6;379(23):2220-2229 - PubMed
  40. Nature. 1981 May 28;291(5813):335-8 - PubMed
  41. Cancer Res. 1995 Sep 1;55(17):3847-53 - PubMed
  42. Cell. 1994 Jan 28;76(2):241-51 - PubMed
  43. Ann Oncol. 1995 Nov;6(9):921-6 - PubMed
  44. J Exp Med. 1996 Jun 1;183(6):2533-40 - PubMed
  45. Clin Microbiol Rev. 1996 Oct;9(4):532-62 - PubMed

Publication Types